Masimo Gross Profit 2010-2024 | MASI
Masimo annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Masimo gross profit for the quarter ending September 30, 2024 was $0.263B, a 12.1% increase year-over-year.
- Masimo gross profit for the twelve months ending September 30, 2024 was $1.022B, a 3.02% decline year-over-year.
- Masimo annual gross profit for 2023 was $1.004B, a 5.22% decline from 2022.
- Masimo annual gross profit for 2022 was $1.059B, a 30.97% increase from 2021.
- Masimo annual gross profit for 2021 was $0.808B, a 8.8% increase from 2020.
| Masimo Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $1,004 |
| 2022 | $1,059 |
| 2021 | $808 |
| 2020 | $743 |
| 2019 | $629 |
| 2018 | $575 |
| 2017 | $522 |
| 2016 | $478 |
| 2015 | $410 |
| 2014 | $391 |
| 2013 | $359 |
| 2012 | $326 |
| 2011 | $294 |
| 2010 | $286 |
| 2009 | $249 |
| Masimo Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $263 |
| 2024-06-30 | $255 |
| 2024-03-31 | $242 |
| 2023-12-31 | $263 |
| 2023-09-30 | $235 |
| 2023-06-30 | $221 |
| 2023-03-31 | $285 |
| 2022-12-31 | $313 |
| 2022-09-30 | $283 |
| 2022-06-30 | $258 |
| 2022-03-31 | $205 |
| 2021-12-31 | $215 |
| 2021-09-30 | $204 |
| 2021-06-30 | $193 |
| 2021-03-31 | $197 |
| 2020-12-31 | $187 |
| 2020-09-30 | $179 |
| 2020-06-30 | $192 |
| 2020-03-31 | $186 |
| 2019-12-31 | $167 |
| 2019-09-30 | $156 |
| 2019-06-30 | $154 |
| 2019-03-31 | $152 |
| 2018-12-31 | $148 |
| 2018-09-30 | $141 |
| 2018-06-30 | $142 |
| 2018-03-31 | $144 |
| 2017-12-31 | $139 |
| 2017-09-30 | $124 |
| 2017-06-30 | $127 |
| 2017-03-31 | $132 |
| 2016-12-31 | $139 |
| 2016-09-30 | $110 |
| 2016-06-30 | $115 |
| 2016-03-31 | $114 |
| 2015-12-31 | $102 |
| 2015-09-30 | $102 |
| 2015-06-30 | $103 |
| 2015-03-31 | $103 |
| 2014-12-31 | $109 |
| 2014-09-30 | $96 |
| 2014-06-30 | $93 |
| 2014-03-31 | $92 |
| 2013-12-31 | $91 |
| 2013-09-30 | $87 |
| 2013-06-30 | $91 |
| 2013-03-31 | $90 |
| 2012-12-31 | $87 |
| 2012-09-30 | $78 |
| 2012-06-30 | $81 |
| 2012-03-31 | $79 |
| 2011-12-31 | $74 |
| 2011-09-30 | $68 |
| 2011-06-30 | $75 |
| 2011-03-31 | $77 |
| 2010-12-31 | $74 |
| 2010-09-30 | $72 |
| 2010-06-30 | $70 |
| 2010-03-31 | $70 |
| 2009-12-31 | $66 |
| 2009-09-30 | $62 |
| 2009-06-30 | $60 |
| 2009-03-31 | $61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.326B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.416B | 24.94 |
| Intuitive Surgical (ISRG) | United States | $192.946B | 100.88 |
| Alcon (ALC) | Switzerland | $43.080B | 28.83 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $36.405B | 20.06 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $31.603B | 47.59 |
| Waters (WAT) | United States | $22.979B | 33.98 |
| STERIS (STE) | Ireland | $21.385B | 24.62 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.978B | 0.00 |
| Hologic (HOLX) | United States | $17.581B | 18.99 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.691B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $13.362B | 41.90 |
| Globus Medical (GMED) | United States | $11.588B | 29.34 |
| Penumbra (PEN) | United States | $9.412B | 92.19 |
| Teleflex (TFX) | United States | $8.737B | 13.94 |
| Glaukos (GKOS) | United States | $7.499B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.035B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.735B | 26.84 |
| Veracyte (VCYT) | United States | $3.384B | 101.54 |
| Inari Medical (NARI) | United States | $3.018B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.803B | 16.18 |
| Nihon Kohden (NHNKY) | Japan | $2.421B | 18.39 |
| TransMedics (TMDX) | United States | $2.398B | 76.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.192B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.121B | 19.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.901B | 9.93 |
| RxSight (RXST) | United States | $1.756B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.248B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 82.44 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.875B | 14.87 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.739B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 36.74 |
| Mesa Laboratories (MLAB) | United States | $0.668B | 15.75 |
| AxoGen (AXGN) | United States | $0.635B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.634B | 0.00 |
| SiBone (SIBN) | United States | $0.546B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.533B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 31.04 |
| Pacific Biosciences Of California (PACB) | United States | $0.501B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.453B | 24.53 |
| Delcath Systems (DCTH) | United States | $0.379B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
| Inogen (INGN) | United States | $0.237B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.155B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |